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Summary 
Site-specific deletions in the tal-1 gene are reported to occur in 12-26% ofT cell acute lymphoblastic 
leukemias (T-ALL). So far two main types of tal-1 deletions have been described. Upon analysis 
of 134 T-ALL we have found two new types of tal-1 deletions. These four types of deletions 
juxtapose the 5' part of the tal-1 gene to the sil gene promoter, thereby deleting all coding sil 
exons but leaving the coding tal-1 exons undamaged. The recombination signal sequences (RSS) 
and fusion regions of the tal-1 deletion breakpoints strongly resemble the KSS and junctional 
regions of immunoglobulin/T cell receptor (TCK) gene rearrangements, which implies that 
they are probably caused by the same V(D)J recombinase complex. Analysis of the 134 T-ALL 
suggested that the occurrence of tal-1 deletions is associated with the CD3 phenotype, because 
no tal-1 deletions were found in 25 TCR-3'/~ + T-ALL, whereas 8 of the 69 CD3- T-ALL and 
11 of the 40 TCR-odB + T-ALL contained such a deletion. Careful examination ofall TCR genes 
revealed that tal-1 deletions exclusively occurred in CD3- or CD3 § T-ALL of the cr/j3 lineage 
with a frequency of 18% in T-ALL with one deleted TCR-~ allele, and a frequency of 34% 
in T-ALL with TCR-fi gene deletions on both alleles. Therefore, we conclude that ol/j3 lineage 
commitment of the T-ALL and especially the extent of TCK-/~ gene deletions determines the 
chance of a tal-1 deletion. This suggests that tal-1 deletions are mediated via the same deletion 
mechanism as TCP,-/~ gene deletions. 
e~.rrent chromosomal berrations, uch as transloca- 
ions and inversions involving the Ig and TCR loci, 
are nonrandomly associated with lymphoid malignancies. It 
is generally assumed that these chromosome aberrations are 
caused through "illegitimate" V(D)J recombinase activity by 
the enzyme system, which normally provides for the rear- 
rangement processes in Ig and TCR gene complexes (1-5). 
The reciprocal t(1;14)(p32;q11) is an example of a chromo- 
some aberration that is probably caused by "illegitimate" V(D)J 
recombination. This translocation is exclusively found in T 
cell acute lymphoblastic leukemia (T-ALL) 1 and involves 
1 Abbreviations u ed in this paper: hprt, hypoxanthine-guanine phosphoribo- 
syltransferase; MNC, mononuclear cells; KSS, recombination signal 
sequence; T-ALL, T cell acute lymphoblastic leukemia; TdT, terminal 
deoxynucleotidyl transferase. 
both the so-called tal-1 gene (also known as SCL or TCLS) 
and the TCK-~ gene complex (6-10). Approximately 3% of 
pediatric T-ALL have a t(1;14) (11), and six of the seven trans- 
location breakpoints analyzed to date cluster in the D/~-J~ 
region of the TCK-/$ locus on chromosome 14 and in a 1-kb 
region of the 5' part of the ta/-1 locus on chromosome 1 (8-10). 
The tal-1 gene is a transcriptionally complex locus in which 
the 5' noncoding region has two distinct ranscription i iti- 
ation sites and a variable pattern of alternative exon utiliza- 
tion (12-14). At least six different forms of mKNA are ex- 
pressed, predominantly in early hematopoietic cells (13-15). 
The TAL-1 protein contains aso-called helix-loop-helix DNA 
binding motif (HLH motif) (12, 13, 16, 17), which is also 
found in several other proteins involved in control of cell 
proliferation or differentiation (18-21). Therefore, disregula- 
tion of the tal-1 gene expression by chromosomal berrations 
may contribute to the leukemic transformation i  T-ALL. 
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The 5' part of the tal-1 locus can also be affected by a site- 
specific, submicroscopic deletion (tal-1 deletion) of '~90 kb, 
which occurs at high frequency in T-ALL only (14, 22, 23). 
As a result of this "~90-kb deletion the coding exons of the 
tal-1 gene are juxtaposed to the first noncoding exon of the 
recently described sil gene (24), which is therefore almost 
completely deleted (see Fig. 1 A). The expressed sil-tal-1 fu- 
sion mRNA produces anormal TAL-1 protein, but is tran- 
scriptionally controlled by the sil gene promoter (14, 25). 
Also tal-1 deletions are assumed to be caused by the V(D)J 
recombinase ystem, because the breakpoints seem to cluster 
at heptamerononamer recombination signal sequences (RSS) 
(14, 25), which are homologous to those used in the Ig and 
TCR rearrangement processes (4, 5, 26-28). Moreover, the 
fusion regions of the tal-1 deletion breakpoints how non- 
templated nucleotide addition (N region), P region nucleo- 
tides, and deletion of nucleotides by exonucleic nibbling from 
the flanking sequences, all of which are hallmarks of V(D)J 
recombination processes in Ig and TCR genes (5, 26, 29). 
So far three types of tal-1 deletions are described. The two 
main types of tal-1 deletion use the same 5' heptamer RSS, 
located between the first and second sil exon, but different 
3' heptamer-nonamer RSS in the 5' part of the tal-1 locus, 
1.7 kb apart of each other (14, 25), whereas the third type 
(type C) has only been found in one patient and does not 
use any RSS (25). In our attempt o determine the occur- 
rence of the tal-1 deletions in a series of 134 T-ALL, we 
identified two new types of tal-1 deletions that use the same 
5' heptamer RSS as types I and 2, but different 3' heptamer- 
nonamer RSS. In contrast o suggestions in other publica- 
tions (14, 25), the ta/-1 deletions exclusively occurred in T-ALL 
of the o~/~/T cell lineage and were especially correlated with 
TCR-/~ gene deletions, which are characteristic for the o~/~/ 
lineage. 
Materials and Methods 
Cell Samples. Cell samples were obtained from a nonrandom 
group of 134 T-ALL patients at initial diagnosis. To obtain sufficient 
numbers of CD3 + T-ALL (especially TCR-"//~ + T-ALL), we have 
selected T-ALL cell samples based on their CD3/TCR im- 
munophenotype, r sulting in 69 CD3- T-ALL (51% of the total 
series), 40 TCR-c~/~ + T-ALL (30%), and 25 TCR-'~/6 + T-ALL 
(19%). In random series of T-ALL, this immunophenotype distri- 
bution probably is ,~70, "~20, and ,'~10%, respectively (30). 
Mononuclear cells (MNC) were isolated from peripheral blood, 
bone marrow, or pleural exadate by Ficoll-Paque (density, 1.077 
g/ml; Pharmacia, Uppsala, Sweden) density centrifugation. The 
cell samples were frozen and stored in liquid nitrogen. 12 T cell 
lines were included as positive or negative controls (CEM, HPB- 
ALL, MOLT16, JURKAT, H9, HUT78, DND41, PEER, RPMI- 
8402, MOLT4, HSB-2, GH1) (31). 
Immunologic Marker Analysis. The MNC of the T-ALL patients 
were analyzed for nuclear expression ofterminal deoxynucleotidyl 
transferase (TdT), for cytoplasmic expression ofTCR-/~ (~F1), for 
cell membrane expression of T cell markers CD1 (66IIC7), CD2 
(Leu-5b), CD3 (Leu-4), CD4 (Leu-3a), CD5 (Leu-1), CD6 
(OKT17), CD7 (3A1), and CD8 (Leu-2a), for HLA-DR antigen, 
and for reactivity with the mAbs BMA031 (anti-TCR-~/~), 11F2 
(anti-TCR-3,/8), and TCR-61 (anti-TCR-8). The rabbit anti-TdT 
antiserum was purchased from Supertechs (Bethesda, MD); the 
mAbs of the Leu series, anti-HLA-DR and 11F2, were obtained 
from Becton Dickinson & Co. (San Jose, CA); the CD1 antibody 
was obtained from Monosan/Sanbio (Nistelrode, The Netherlands); 
OKT17 was from Ortho Diagnostic Systems (Raritan, NJ); the 
3A1 hybridoma was from the American Type Culture Collection 
(RockviUe, MD); TCR-81 and BF1 were obtained from T Cell Di- 
agnostics (Cambridge, MA). The mAb BMA031 was kindly 
provided by Dr. R. Kurrle (Behring, Marburg, Germany). Im- 
munofluorescence stainings were evaluated with fluorescence micro- 
scopes (Carl Zeiss, Inc., Oberkochen, Germany) and/or a FACScan | 
flowcytometer (Becton Dickinson & Co.). 
Isolation of the tal-1 Locus fwm a Genomic Library. Screening with 
the B2EE-2.0 (9) and TALDB2 probes of the CML-0 genomic li- 
brary, constructed of MboI partial digested DNA from a chronic 
myeloid leukemia (CML) patient cloned in the EMBL3 X replace- 
ment vector (32), yielded several phage inserts, which covered the 
whole ta/-1 locus. The phage inserts were digested for restriction 
enzyme analysis and some genomic restriction fragments were sub- 
cloned in the pUC19 cloning vector. 
Isolation of sil and tal-1 Gene DNA Probes. DNA probes were 
obtained by cloning the purified PCR amplification products of 
granulocyte DNA from a healthy donor using specific oligonucle- 
otide primer sets. pUC19 was used as cloning vector (32). The 
oligonucleotide primer sets for the SILDB and TALDB2 probes, 
including the artificial tails containing restriction sites for cloning, 
are given in Table I. All oligonucleotides were synthesized according 
to published ta/-1 gene sequences (13, 14, 22) on a DNA synthesizer 
(392; Applied Biosystems, Inc., Foster City, CA) with the solid- 
phase phosphotriester method and used without further purification. 
Probe TALDB1 was isolated by cloning an "~800-bp MspI-MspI 
fragment, containing the 3' side of the ta/-1 deletion type 1 (Fig. 
1 A), from the CMb0 genomic library (33). 
Southern Blot Analysis. DNA was isolated from frozen MNC 
as described previously (32, 34). A 15-#g sample was digested with 
the appropriate r striction enzymes (Pharmacia), size-fractionated 
on 0.7% agarose gels, and transferred toNytran-13N nylon mem- 
branes (Schleicher & Schuell, Inc., Dassel, Germany) as described 
(32, 34). tal-1 deletions were studied using 3zp random oligonu- 
cleotide-labeled B2EE-2.0 (9), TALDB1, TALDB2, and SILDB 
probes in EcoRI, HindlII, and BgllI digests. TCR-~ gene rear- 
rangements were detected with the JB1, J/~2, and CB probes (34, 
35) in EcoRI and HindlII digests. The configuration ofthe TCR-y 
genes was analyzed by use of theJ~/1.2, J~/1.3, J'y2.1, and C'y probes 
(34, 36) in EcoRI and KpnI digests. The configuration fthe TCR-6 
genes was analyzed by use of the V~I, V63, J/$1, J~2, C~, 6~Ec, 
and ~bJc~ probes (34, 37-40) in EcoRI, HindlII, and BgllI digests. 
PCR Amplification Analysis. PCR was essentially performed 
as described previously (32, 41). A 0.1-/~g sample of DNA, 12 pmol 
of the 5' and the 3' oligonucleotide primer, and 1 U of AmpliTaq 
DNA polymerase (Perkin-Elmer Cetus, Norwalk, CT) were used 
in each PCR reaction of 100/~1. The oligonucleotide primers are 
listed in Table 1. These oligonucleotides were designed according 
to our own sequence data and published tal-1 (14) and sil gene se- 
quences (22). The PCR reaction mixture was incubated at 94~ 
for 3 min, at 60~ for 2 min, and at 72~ for 3 min in a thermal 
cycler (Perkin-Elmer Cetus). After this initial cycle, denaturing, 
annealing, and extension steps were performed for another 39 cycles 
at 94~ for 1 min, at 60~ for 1 min, and at 72~ for 3 min, 
respectively. After the last cycle an additional extension step of 72~ 
for 7 min was executed. The PCR products of ta/-1 deletion types 
I and 2 were size fractionated by 10% polyacrylamide g l-electro- 
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phoresis and visualized by ethidium bromide staining to demon- 
strate differences in ize. 
Sequence Analysis. 1 #1 of the original PCR product, 12 pmol 
of the limiting primer, 600 pmol of the opposite primer, and 5 
U ofAmpliTaq DNA polymerase (Perkin-Elmer Cetus) were used 
in each asymmetric PCK reaction of 500/zl. The reaction mixture 
was incubated for a total of 25-30 cycles with the above-described 
regular temperature cycles. After the asymmetric amplification, the 
PCK product was precipitated twice in 50% ethanol plus 0.1 vol 
of 2 M NaAc, pH 5.6 (41). The dried pellet was resolved in 22 
/A H20, half of which was used in the sequence reaction. 50-pmol 
sequence primer was used in each reaction (sequence primers are 
indicated in Table 1). All sequence reactions were performed with 
the T7-sequencing kit (Pharmacia) following the manufacturer's 
instructions using 3sSradiolabeling, and run on a normal, dena- 
turing 8% polyacrylamide sequence gel. All germline sequences 
and fusion regions of tal-1 deletions were sequenced in both 
directions. 
Results 
Two New Types of tal-I Deletions. Screening of 134 T-ALL 
by Southern blot analysis revealed two new types of tal-1 de- 
letions in addition to the already described types 1 (type A), 
2 (type B), and C (14, 25). We designated these new tal-1 
deletions types 3 and 4 (Figs. 1 A and 2). Based on the 
Southern blot data, it was concluded that the 3' breakpoints 
of these two new tal-1 deletions were located upstream of 
the tal-1 locus, whereas the 5' breakpoints were apparently 
identical to the 5' breakpoints of tal-1 deletions types 1 and 
2 (Figs. 1 A and 2). To determine the exact location and the 
germline sequences ofthe new ta/-1 deletion breakpoints, DNA 
of patient MB with tal-1 deletion type 3 was amplified by 
PCR using the sildb and talldb2 oligonucleotide primers (Table 
1), which resulted in an *3-kb PCR product. After cloning 
and sequencing of this PCK product, a ta/-1 deletion type 
3 sequence primer was made (Table 1). A 4.3-kb XbaI-XbaI 
fragment isolated from a genomic library was sequenced by 
use of the talldb3-seq primer, which provided the germline 
sequence of the tal-1 deletion type 3 breakpoint region (Fig. 
1 B). Based on the sequencing data of the 3' side of a 1.9-kb 
SalI-XbaI subclone, the talldb4 primer was made (Table 1). 
This primer in combination with the sildb primer resulted 
in an '~0.6-kb PCK product when DNA from patient BD 
with tal-1 deletion type 4 was amplified. Based on the direct 
sequencing data of this PCR product, a ta/-1 deletion type 
4 sequence primer was made (Table 1). Sequencing with this 
primer of the 1.9-kb SalI-XbaI subclone provided the germ- 
line sequence of the tal-1 deletion type 4 breakpoint region 
(Fig. 1 B). 
The sequence analysis howed that the tal-1 deletion types 
3 and 4 both used the same 5' heptamer RSS as types 1 and 
Figure 1. Restriction map and germline s quences of tal-1 deletion breakpoint regions. (A) Restriction map of the ta/-1 locus and the 5' part of 
the sil gene involved in the ,'~90-kb ta/-1 deletion. Thevarious types of ta/-1 deletion breakpoints are indicated w th arrows: sildb, breakpoint in sil 
gene; taldb, breakpoints in tal-1 gene. Noncoding exons are indicated as otted boxes; solid boxes represent protein-coding exons. The HLH motif 
is indicated in ta/-1 exon 6 (12, 13). The relevant restriction sites are indicated: B, BamHI; Bg, BgllI; E, EcoR.I; H, HindlII; $, SacI; X, Xbal; * 
Polymorphic restriction site. Op n boxes below the restriction map represent the probes used for Southern blot hybridization. (/3) Germline sequences 
surrounding the breakpoints of the various types of tal-1 deletions. The heptamer sequence of the 5' RSS in the sil gene and heptamer-nonamer sequences 
of the 3' RSS in the ta/-1 gene are underlined. The arrow indicates the location of the breakpoints. 
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Figure 2. Southern blot analysis of the various types of ta/-1 ddetions. 
HindlII digests of DNA from patients with different types of tal-1 deletion: 
type 1, patient SL; type 2, patient PV; type 3, patient MB; type 4, patient 
BD. The Southern blot filter was successively h bridized with the SLLDB 
and TALDB1 probes (Fig. 1 A). The sizes of the rearranged bands re 
indicated. G, germline band. 
2, but different Y heptamerononamer RSS (Fig. 1 B). The 
heptamer-nonamer RSS for tal-1 deletion type 2 is located 
"~1.7 kb upstream of the type 1 RSS (14, 25), whereas the 
RSS of types 3 and 4 are located *4.5 and ',~7.7 kb upstream 
of the type 1 RSS, respectively (Fig. 1 A). The RSS of all 
tal-1 deletions display a strong homology with the heptamer- 
nonamer RSS sequences of Ig and TCR genes. 
Fusion Regions of tal-1 Deletion Breakpoints. In total, 19 
ta/-1 deletions were found in the 134 T-ALL analyzed: 14 type 
1, three type 2, one type 3, and one type 4 (Table 2). In addi- 
tion, four T cell lines (RPMI 8402, HSB-2, CEM, MOLT 
16) contained a type 1 ta/-1 deletion. PCR products containing 
the fusion regions of the tal-1 deletion breakpoints were ob- 
tained by amplification of the different al-1 deletions from 
the 19 T-ALL and 4 T cell lines (Fig. 3 A). Subsequent se- 
quencing of the tal-1 deletion PCR products revealed the se- 
quences of the breakpoint fusion regions (Fig. 3 B). All fu- 
sion regions contained randomly inserted nucleotides (N 
region) except for patient MD, who had a fusion region con- 
sisting of two P region nucleotides only. The average N re- 
gion insertion was 6.4 nucleotides, and a total of 14 P region 
nucleotides were observed in the 23 fusion regions analyzed 
(19 T-ALL and 4 T cell lines). Trimming occurred in the far 
majority of the tam deletions. Thus, the fusion regions are 
highly homologous to the junctional regions of rearranged 
Ig and TCR genes. 
Table 1. Oligonucleotide Primers Used in PCR and Sequencing Analysis of tal-1 Deletions or Isolation of DNA Probes 
Code Position/size* Sequence: Reference s 
tal-1 deletion 
5' all types 
3' type 1 
3' type 2 
3' type 3 
3' type 4 
DNA probes 
SILDB 
TALDB2 
sildb - 155 
sildb-seq - 111 
talldl + 155 
talldbl-seq + 111 
talldbl-5' + 28 
talldb2 + 152 
talldb2-seq + 110 
talldb3 + 58 
talldb3-seq + 15 
talldb4 + 450 
talldb4-seq § 34 
sildp5' 330 
sildpY 
talld2pS' ,~575 
talld2pY 
5 s 3' 
GGGGAGCTCGTGGGAGAAATTAAG 22 
GGTATCATCTGAGCTAAGGTATGTG 22 
GCCTCGAAGGGTCCACATCTAC 14 
CACACTCGGACACAGAGCCTG 14 
TCACAATCCCACCGCATGCACA 14 
TTGTAAAATGGGGAGATAATGTCGAC This paper 
AACTTATATGACCTTTAAAAGG This paper 
TGCATGCACTCTGATGAGCAGCC This paper 
ATCTACACTGCAGTTACTGTGTGAC This paper 
GGATTATAGGTGCCTGTCACCAC This paper 
TACATCTTATAGTATGTAAATTATGCC This paper 
CACAGGATCCTTGATCCTGGAGCGC 22 
CCGAAGCTTCCGCGGAGCTGAGGTCTG 22 
TGTAAGCTTTGGCTAAGTCACATCTCTC 14 
CCTGTCAATAGGGACATAAATGCC 13 
*The position of the oligonucleotide primer s indicated upstream ( - ) or downstream ( + ) relative to the heptamer RSS. The sizes of the DNA 
probes are given. The position of the DNA probes are indicated in Fig. 1 A. 
* The underlined sequences represent the aspecific nucleotides, which generate restriction sites. 
s Sequence information used to esign the oligonucleotide primers was derived from the indicated literature references or from our own sequence data. 
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Table 2. Frequency of tal-1 Deletions in T-ALL 
No. of 
T-ALL patients Type 1 
ta/-1 deletions 
Type 2 Type 3 Type 4 Total 
CD3- 69 8.7070 (6)* 
TCP,,-.y/8 + 25 0% (0) 
TCR-,x/~ § 40 20070 (8) 
Total 134 10.4% (14) 
2.9~ (2) 0070 (0) 0070 (0) 11.607o (S) 
0070 (0) 0070 (0) 0070 (0) 0070 (0) 
2.5070 (1) 2.5070 (1) 2.5% (1) 27.5% (11) 
2.2070 (3) 0.7070 (1) 0.7070 (1) 14.207o (19) 
* No. of deletions. 
Occurrence of tal-1 Deletions Is Related to CD3 Phenotype and 
TCR Gene Configuration. The overall percentage oftal-1 de- 
letions in our series ofT-ALL was 14.2% (19/134), but these 
tal-1 deletions appeared to be restricted to CD3- T-ALL 
(8/69) and TCR-od3 + T-ALL (11/40), whereas no ta/-1 de- 
letions were found in TCP,-'y/~ + T-ALL (0/25) (Table 2). 
The presence or absence of tal-1 deletions was not associated 
with other immunophenotypic characteristics (Table 3). 
Since CD3- T-ALL theoretically represent precursor 
stages of both TCR-3,/~ + and TCR-cd3 + T-ALL, we tried 
to use the configuration of the TCR-~ genes as an additional 
marker to determine whether the CD3- T-ALL group could 
be divided into "r/~ lineage or c~/3 lineage committed sub- 
groups, and whether such a subdivision corresponded with 
the occurrence of tal-1 deletions. The configuration of the 
TCR-~ gene on each allele can potentially pass three con- 
secutive stages: germline, rearranged, and deleted. Analysis 
of the TCR-~ gene configuration of the 19 T-ALL and 4 T 
cell lines with tal-1 deletions revealed that all but one con- 
tained at least one deleted TCR-~ allele (Table 3): only one 
T-ALL (1/19) with a tal-1 deletion had no deletion of the 
TCR-~ gene, 31.6% (6/19) had one deleted TCR-~ allele 
with a rearrangement onthe other allele, and 63.2% (12/19) 
had deletions of both TCR-~ alleles. Also in the four T cell 
lines with a tal-1 deletion, a high frequency of TCR-~ gene 
deletions was found: seven of eight TCR-~ alleles were deleted 
(Table 3). 
Further analysis of the eight TCR-~ gene rearrangements 
in the T-ALL with a tal-1 deletion showed that seven were 
complete V~-J~ rearrangements, and one TCR-odB + T-ALL 
(patient MG) contained a Vol-J61 rearrangement (Table 4). 
Sequence analysis of the seven V$-J~ junctional regions re- 
vealed that all these TCR-~ rearrangements in both CD3- 
T-ALL and TCR<z/B + T-ALL were out of frame and there- 
fore nonfunctional (Fig. 4). The rearranged TCR-6 gene in 
cell line RPM18402 is caused by a t(ll;14)(plS;q11) and there- 
fore represents a nonfunctional TCR-$ gene as well (39). This 
implies that all T-ALL and T cell lines with a tal-1 deletion 
have deleted their TCR-~ genes (37/46 alleles) and/or con- 
tain nonfunctional TCR-~ gene rearrangements (9/46 alleles). 
TCR-~ gene analysis of the T-ALL and T cell lines with 
a tab1 deletion revealed that 21.7% (10/46) and 78.3% (36/46) 
of the rearranged TCR-'y alleles involved the TCR-'rl and 
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TCR.-'y2 locus, respectively (Table 3), which represents a 
normal rearrangement pattern, as found in the total group 
of 134 analyzed T-ALL. Analysis of the TCK-fl configura- 
tion of the 19 T-ALL and 4 T cell lines revealed rearrange- 
ments in all cases, but without any preferential pattern. 
tal-1 Deletions Coincide with TCR-~ Gene Deletions. Based 
on the above-described results, we decided to determine the 
incidence of TCK-5 gene rearrangements and deletions in 
the total group of 134 T-ALL. The results allowed us to divide 
the 134 T-ALL in subgroups on the basis of their TCK-~ 
gene configuration i  addition to their CD3 phenotype, as 
presented in Table 5. It became clear that in the CD3- 
T-ALL group almost all tal-1 deletions (7/8) duster in a small 
subgroup (39% of all CD3- T-ALL), which is defined by 
containing at least one deleted TCK-~ allele. Since TCR- 
odfl + T-ALL also contain at least one deleted TCK-~ allele, 
virtually all ta/-1 deletions coincide with TCR-~ gene deletions. 
In addition, it is remarkable that the far majority of ta/-1 
deletions in TCK-odB + T-ALL (9/11) duster in the major 
subgroup, which is defined by deletion of both TCR-~ al- 
leles (63% of all TCR-od3 + T-ALL). Only two TCK-~//~ + 
T-ALL (2/25) had one deleted TCR-8 gene, and no tal-1 de- 
letions were found in this CD3 + subgroup. The overall 
results show that the frequency of ta/-1 deletions in T-ALL 
with both TCR-5 alleles deleted (34.3%) is about wice that 
of tal-1 deletions in T-ALL with one TCR-8 allele deleted 
(17.6%) (Table 5). This suggests that not the CD3 im- 
munophenotype, but the extend of TCR-8 gene deletion de- 
termines the chance of having a tal-1 deletion. This is further 
supported by the finding that only one ta/-1 deletion was found 
in the 65 T-ALL without a TCR-8 gene deletion, in contrast 
to 18 of the 69 T-ALL with one or two deleted TCR-8 genes. 
Configuration of 3REC and ~/jcx Gene Segments in T-ALL with 
a tal-1 Deletion. The TCR-8 deletion mechanism, which is 
responsible for the deletion of nonfunctional ~CR-8 rear- 
rangements, i  assumed to use two so-called eleting elements, 
8R~c and 1/,Jcz (40, 42). The specific ~R~c-~Jo~ rearrangement 
was found in three T-ALL and one T cell line with a tal-1 
deletion (Table 4). In one T-ALL (patient BD) this rearrange- 
ment was present only in a small subpopulation of the leu- 
kemic cells (Table 4). 80.4% (37/46) of the 6REC alleles and 
78.3% (36/46) of the ~Jo~ alleles were deleted in the T-ALL 
and T cell lines with a tal-1 deletion. Only two TCR-od8 
Figure 3. PCR and sequence analysis of ta/-1 
deletion fusion regions. (A) PCR products obtained 
via amplification f the DNA from patients with 
tal-1 deletion types 1 or 2 were size fractionated 
in an ethidium bromide-stained 10% polyacryl 
amide gel. The PCR reaction was performed using 
the sildb primer and either the talldbl primer (type 
1) or talldb2 primer (type 2). (B) Sequences of the 
fusion regions of all tal-1 deletions arealigned with 
the known (underlined) sil and tal germline se- 
quences. Lower-case characters t the end of a fu- 
sion region represent P region nucleotides (29). 
All other nucleotides of the fusion region repre- 
sent N region nucleotides. 
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Table 4. TCR-r Rearrangements and Configuration of Deleting Elements in I9 T-ALL and 4 T Cell Lines with a tal-1 Deletion 
Deleting elements 
T-ALL patients CD3 TCR-8 
and cell lines* phenotype rearrangements 8R~c ~bJce 
PV CD3- Vb1-J81/V81 -J81 D/D G/G 
MV CD3- 61~c-r P,./G R /G 
DR CD3- D/V83-J81 D/G D/G 
SL CD3- D/V81-J~51 D/D D/G 
CW CD3- D/V81-J81 D/D D/G 
HSB-2 CD3- D/SREc-r R /R  D/R  
RPMI 8402 CD3- D/t(11;14) D/G D/D 
MvG CD3- D/D D/D D/D 
JN CD3- D/D D/D D/D 
TH CD3- D/D D/D D/D 
CEM CD3- D/D D/D D/D 
MD oe/fl + D/V81-J81 DID DIG 
MG oe/fl § D/Vce-J~51 D/D D/D 
RK ot/fl § D/SR~c-~/,Jot D /R  D/R  
BD cg/fl + D/D/cSREc-~bJ~* D/D/R* D/D/R* 
YB c~/fl § D/D D/D D/D 
AG ~x/fl + D/D D/D DID 
PM ~/fl+ D/D D/G D/D 
RS oell3 + DID D/G DID 
JO ~x/fl + DID D/D D/D 
JW cxlfl + DID DID DID 
MB c~/fl + DID D/D D/D 
Molt 16 cuff + D/D DID DID 
Gene configuration: G, allele in germline configuration; R, rearranged allele; D, deleted allele. 
* The T-ALL and T cell lines are ordered according to their immunophenotype (first CD3-, followed by TCR-cUfl § and the configuration of 
their TCR-/~ genes (i.e., from V~-J~5 rearrangement and ~a~c-~bJc~ rearrangement to deletion). 
~SRsc-~kJcr rearrangement present in a small subpopulation. 
V61 Junctional region J61 
CTCTTGGGGAACT AC~CC GATAAACT 
Patients 
$L CTCTTGGGGA CCCCCGGAAATAGTaGGACGGA ACCGATAAACT 
MD CTCTTGG CTTTCTCTCCGGgt ACTGGGGGATTTgt ACACCGATAAACT 
PV CTCTTGGG CAATTTGGTTCAGTCATTTATGACCCCAAGGGGATAATT CACCGA~---AAACT 
PV CTC GACGCCGC ACACCGATAAACT 
C~N CTCTTGGGGA GCTGAGATCCCCG~CCTCCCAGGGAGCGCGGGGACCTAt CACCGA~-~CT 
V63 
ACTGTGCCTTTAG 
DR ACTGTGCCTTTA AGGACTGGGCCGGC, GCGGGATGGGGG T 
J62 
CTTTGACAGC~CA 
GACAGCACA MV ACTGTGCCTTT CT TACTG CCGGGA~GGAGGGGAG 
Figure 4. Junctional region se- 
quences of nonfunctional TCP.-~ 
rearrangements in T-ALL with a 
tal-1 deletion. Sequences of the junc- 
tional regions of the TCR-8 rear- 
rangements are aligned with the 
known (underlined) V8 and J8 germ- 
line sequences (37). All rearrange- 
ments are out of frame. Underlined 
sequences in the junctional regions 
represent D8 nucleotides. Lower- 
case characters epresent P region 
nudeotides, and all other junctional 
region nucleotides represent N re- 
gion nucleotides. Overlined se- 
quences are stop codons when read 
in the correct reading frame. 
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Table 5. Frequenc 7 of tal-1 Deletions in T-ALL Subgroups Defined by CD3 PhenotTpe and TCR~ Gene Configuration 
TCR-fi gene configuration 
tal-1 deletions in: G/G R/G R/P,. D/P, D/D 
% 
CD3- T-ALL 0 0 3.3 23.5 30.0 
(8/69) (0/7) (0/5) (1/30) (4/17) (3/10) 
TCR-7/~ + T-ALL - - 0 0 - 
(0/25) (0/0) (0/0) (0/23) (0/2) (0/0) 
TCR-c~//~ +T-ALL - - - 13.3 36.0 
(11/40) (0/0) (0/0) (0/0) (2/15) (9/25) 
Total T-ALL 0 0 1.9 17.6 34.3 
(19/134) (0/7) (0/5) (1/53) (6/34) (12/35) 
* TCR-~ configuration: G, allele in germline configuration; R, rearranged allele; D, deleted allele. 
loci were left with both deleting elements in germline configu- 
ration on the same allele (Table 4). It is noteworthy that both 
these two TCR-od~ loci contained a TCR-~ gene rearrange- 
ment of the V~3 gene segment, which can only be obtained 
via inversion of the TCR-~ locus (Table 4). This inversion 
might inhibit ~R~c-~Jol rearrangements. This would imply 
that further TCR-~ gene deletions by specific ~c-~Jo~ rear- 
rangements are impossible in the T-ALL with a tal-1 deletion. 
Discussion 
Five Types oftal-1 Deletions. So far two main types oftal-1 
deletions have been reported, types 1 and 2 (14, 25). Here 
we describe two new types of tab1 deletions, designated types 
3 and 4. Whereas types I and 2 were found in relatively high 
frequencies (10.4 and 2.2%, respectively) in our series of 
T-ALL, types 3 and 4 were each observed only once (0.7%). 
The rare type C tal-1 deletion described by Aplan et al. (25) 
is an unusual deletion because it does not use any RSS (Aplan's 
types A and B are types 1 and 2, respectively). 
All types of tal-1 deletions result in a complete deletion 
of the coding exons of the sil locus, but leave the tal-1 coding 
exons undamaged. Thus, the oncogenic effect of the tal-1 de- 
letions is not the result of an alteration of the TAL-1 protein, 
but an aberrant expression of the normal TAL-1 protein, which 
may contribute to the leukemic transformation f immature 
T cells into T-ALL 
RSS Used in tal-I Deletions. The tal-1 deletion types 1, 
2, 3, and 4 use the same 5' RSS, which consists of a hep- 
tamer sequence only and is located between the first and second 
noncoding sil exons. The 3' RSS used in these tal-I deletions 
consist of different heptamer-nonamer sequences, with spacers 
of 24 nucleotides (types 1 and 3) or 12 nucleotides (types 
2 and 4). All four 3' RSS are located in the noncoding 5' 
part of the tal-1 locus. These 3' RSS are highly homologous 
to the consensus RSS used in regular Ig and TCR gene rear- 
rangement processes (Fig. 5) (27, 28). 
Based on several remarkable observations, there has been 
a lot of speculation on the exact mechanism causing the tal-1 
deletions: for instance, the fact that the 3' RSS consists of 
a heptamer-nonamer sequence, whereas the 5' RSS consists 
only of a heptamer with homology to the consensus hep- 
tamer of '~70% (5/7 nucleotides). It can be anticipated that 
such a small heptamer sequence with no demand for abso- 
lute homology will be present at various locations in the 5' 
region of the sil locus. Nevertheless only one "specific" hep- 
tamer is used in all types of tal-1 deletions. In addition, the 
3' RSS of the tam deletion type 2 displays the highest ho- 
mology with the consensus RSS of Ig and TCR genes, but 
this type of tal-1 deletion represents only a minority of the 
total number of tal-1 deletions. Hence, there are other (se- 
quence) factors that contribute to the development ofa tal-1 
recombination event. 
Sequences homologous to the RSS of Ig and TCR genes 
do not only occur in the sil and tal-1 genes, but also in other 
genes, and may lead to recombination a d thereby deletion. 
An example of such site-specific deletions i observed in blood 
Ig/TcR consensus 
tal-1 deletion 
hprt gene deletion 
heptamer nonamer (spacer) heptamer 
CACAGTG GGTTTTTGT (12 /23)  CACTGTG 
- - -TC- -  CC . . . .  CC-  (24)  GG . . . . .  type I 
A . . . . .  G -C  (12)  -T  . . . . .  type2 
. . . .  c - - - c  (24) - -AA- - -  ~m,3  
-T - -CC- -G  ( 12  ) TGA . . . .  type 4 
- - -T  - -A  T - -A  . . . . .  ( 12  ) GTG . . . .  class i 
CT  . . . .  AT -  (23)  -T  . . . . .  dass II 
T . . . . .  G - -  (23)  TTTA-  - -  class III 
Figure 5. RSS used in rearrangement processes of Ig, TCR, ta/-1, and 
hprt genes. The RSS used in the various types of tal-1 deletions orhprt 
deletions are aligned with the consensus heptamer-nonamer sequence of 
Ig and TCR genes (25, 27, 43). (-) Nucleotide homologous to the RSS 
consensus sequence. 
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Table 6. Junctional Diversity of TCR-~ and TCR-y Gene Rearrangements andFusion Region Diversity of tal-1 and hprt Deletions 
No. of inserted nucleotides No. of deleted nucleotides 
Rearrangement/deletion 
(no. of alleles analyzed) Mean Range Mean Range 
TCR-/5 gene rearrangements* 
VS-J~ (n = 45) 28.3 5-47 5.0 0-20 
TCR-'y gene rearrangements* 
V3'-Jy (n = 30) 7.3 0-25 9.1 1-27 
tal-1 deletion fusion regions* 
Type 1 (n = 46) 7.2 0-17 5.6 0-24 
Type 2 (n = 10) 7.5 3-15 5.6 1-14 
Type 3 (n = 1) 8 2 
Type 4 (n = 1) 3 0 
hprt deletion fusion regionsS 
Class I (n = 15) 5.3 0-10 5.2 0-27 
Class II (n = 2) 10.0 8-12 9.5 3-16 
Class III (n = 1) 3 8 
* Data from reference 46. 
* Combined results of this paper and references 14, 22, and 25. 
S Data from reference 43. 
T lymphocytes and involves the housekeeping gene hypoxan- 
thine-guanine phosphoribosyltransferase (hprt) on chromo- 
some Xq26 (43). Three types of deletions have been observed 
in the hprt gene, designated classes I-III, and all three damage 
the gene. The three types of hprt deletions use the same 5' 
KSS, which is located in intron 1 and consists of a sole 
hepatamer, but different 3' RSS, which are located in intron 
3 and consist of heptamer-nonamer s quences with spacers 
of different sizes (Fig. 5). The fusion regions of these hprt 
deletions how N regions, P region nucleotide insertion, and 
deletion of nucleotides by trimming of the flanking sequences, 
and are therefore homologous to the Ig and TCK junctional 
regions and tal-1 breakpoint fusion regions (43). The hprt 
deletions occur at a low frequency of '~10-7 and are not on- 
cogenic (44, 45). 
Fusion Regions of tal-1 Deletion Breakpoints. Because fu- 
sion regions of tal-1 and hprt deletions trongly resemble junc- 
tional regions of normal Ig and TCK gene rearrangements, 
the fusion region nucleotide insertion and deletion of all tal-1 
and hprt deletions described to date were compared to the 
junctional regions of TCK-~5 and TCK- 3' gene rearrangements 
(Table 6). Remarkably, the average insertions observed in the 
tal-1 breakpoint fusion regions (7.2 nucleotides) and the hprt 
breakpoint fusion regions (5.7 nucleotides) were comparable 
to the average insertion of the TCK-3" gene rearrangement 
(7.3 nucleotides), but lower than that of the TCR-~5 gene 
rearrangements (28.3 nucleotides), due to the use of D~ gene 
segments in the latter rearrangement (Table 6) (46). How- 
ever, average nucleotide deletion of the ta/-1 deletions (5.4 
nucleotides) and the hprt deletions (5.8 nucleotides) were less 
extensive than in TCK-3' gene rearrangements (9.1 nucleo- 
tides), but were comparable to TCR-8 gene rearrangements 
(5.0 nucleotides) (Table 6) (46). Although the average nucleo- 
tide deletions of tal-1 deletion types 1 and 2 were identical 
(5.6 nucleotides), the nucleotide deletions at the 5' and 3' 
flanking sides differed markedly between the two types of 
tal-1 deletions. In tal-1 deletion type 1, the average nucleo- 
tide deletion of the 5' flanking side (3.8 nudeotides) was more 
than twice that of the 3' flanking side (1.8 nucleotides), 
whereas in tal-1 deletion type 2 the reversed situation was 
observed with the average nudeotide deletion at the 5' flanking 
side (2.0 nucleotides), being approximately half of that at 
the 3' flanking side (3.6 nucleotides). This difference ismost 
probably related to the different sizes of the spacers in the 
3' KSS of these two types of tal-1 deletions. The type 1 
heptamer-nonamer contains a 24-bp spacer and therefore 
resembles the KSS of a TCK V gene segment, whereas the 
type 2 heptamer-nonamer with a 12-bp spacer esembles the 
KSS of a TCKJ  gene segment (4, 27). So the "J gene-alike" 
side is trimmed twice as much as the "V gene--alike" side 
in both types of tam deletions. This resembles the TCK-3, 
rearrangements where deletion by trimming of the J3' gene 
segments i about wice that of the V3' gene segments (46). 
Also, in hprt deletions this heptamer-spacer-nonamer-related 
nucleotide deletion is observed, where the "J gene-alike" side 
of the hprt deletion class I is trimmed over twice as much 
as the other side. These combined ata suggest that the size 
of the spacer induces direction to the activity of the recombi- 
nation enzyme complex. 
tal-1 Deletions Are Restricted tothe TCR-oe/fl Lineage. tal-1 
deletions are restricted to malignancies of the T cell lineage 
since they have not been discovered in any other hematopoi- 
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etic malignancy tested (8, 22, 25). However, the frequencies 
of the tal-1 deletions in T-ALL differ markedly between the 
reported studies, from 12% (14) to 26% (22). This differ- 
ence may be caused by the compilation of the analyzed series 
of T-ALL. The high frequency of 26% tal-1 deletions may 
be an overestimation caused by an overrepresentation of TCR- 
c~/3 + T-ALL (22), because in our series uch a high fre- 
quency of ta/-1 deletions (27.5%) was only found in the group 
of TCR-oe/3 + T-ALL. However, in the study by Aplan 
et al. (25), almost all tal-1 deletions (10/11) were found 
in CD3- T-ALL, whereas only half of our tal-1 deletions 
(8/19) were found in CD3- T-ALL. 
In our study, tal-1 deletions were detected only in TCR- 
oe/3 + (27.5%) and CD3- T-ALL (11.6%), but not in TCR- 
7/8+ T-ALL. This suggested that the occurrence of tal-1 
deletions i  restricted to T-ALL of the ol/3 differentiation 
lineage. Therefore, we wished to investigate whether the 
CD3- T-ALL with a ta/-1 deletion represented precursors of 
TCR-od3 + T-ALL or precursors of TCR-7/8 + T-ALL. One 
of the present theories concerning the separation of the od3 
and 7/6 differentiation pathways assumes that all T cells that 
do not productively rearrange their TCR- 7 and/or TCR-8 
genes are capable of differentiation into TCR-odB-committed 
T cells by deletion of the TCR-8 locus, which is embedded 
in the TCR-ol locus (30, 40, 42). If so, the configuration 
of the TCR-8 genes in CD3- T-ALL can be used cautiously 
as an o~/3-7/8 lineage marker. Therefore, we divided the 
CD3- T-ALL into two subgroups on basis of their TCR-8 
gene configuration. The first subgroup consisted of CD3- 
T-ALL (n = 42) without deletion of the TCR-8 locus but 
with TCR-8 gene rearrangement i  most of them, and there- 
fore resembled T-ALL of the 7/6 lineage (Table 5). The other 
CD3- T-ALL subgroup (n = 27) had one or both TCR-8 
alleles deleted and therefore may represent an early stage of 
the od[3 lineage. Almost all tal-1 deletions in CD3- T-ALL 
(7/8) were found in this putative o~/3 lineage CD3- sub- 
group, and only one was found in the putative 7/8 lineage 
CD3- subgroup. However, sequencing of the junctional 
regions revealed that all TCR-8 rearrangements in CD3- 
T-ALL with a tal-1 deletion were nonfunctional. Therefore, 
these T-ALL could never express aTCR-8 chain and conse- 
quently belonged to the c~/3 lineage. Thus, all tal-1 dele- 
tions appeared to be restricted to T-ALL of the o~/3 lineage. 
Interestingly, the reported kprt deletions, which are comparable 
to the tal-1 deletions, were found in T cell clones derived 
from mature blood T lymphocytes (45). Although the pre- 
cise TCR-cffB-TCR-7/8 phenotype of these T cell clones 
was not reported, their CD4/CD8 phenotype strongly sug- 
gests that they belonged to the eft3 lineage (45). This would 
be in line with the restriction of tal-1 deletions to the c~/3 
lineage. 
The finding that all tal-1 deletions were detected in the 
TCR-od3 + T-ALL or CD3- T-ALL of the ol/[3 lineage may 
be caused by a combination of two mechanisms. The first 
mechanism is based on the theory that in Ig or TCR gene 
recombination both recombining elements must be transcrip- 
tionally active (2, 4). If tal-1 deletions are indeed caused by 
"illegitimate" V(D)J recombination, the simultaneous expres- 
sion of the sil and tal-1 genes may be a prerequisite for recom- 
bination and thus deletion. This is supported by the findings 
that tal-1 expression i  the few cases tested was restricted 
to TCR-oJ3 + T-ALL and CD3- T-ALL of o~/3 lineage, 
whereas sil expression was not restricted to a particular sub- 
group of T-ALL (24; Breit et al., unpublished results). The 
second mechanism is based on the theory that once both 
TCR-8 alleles are rearranged, but no TCR-7/8 expression 
occurs due to nonfunctional rearrangements of TCR-7 and/or 
TCR-8 genes, the rearranged TCR-8 genes will be deleted 
via a special deletion mechanism involving the 8Rsc and ~bJot 
recombination elements (40, 42). TCR-/$ gene deletion pre- 
pares the allele for subsequent rearrangement of TCR-oe gene 
segments and thereby forces the T cells to differentiate into 
the od3 lineage (30). One might speculate that a special 
TCR-8 gene-deleting recombinase complex is present only 
in T cells of the od3 lineage and is also responsible for the 
taI-1 deletions and hprt deletions. This is supported by the 
finding that the frequency of tal-1 deletions increases with 
the number of deleted TCR-8 alleles. Where in T-ALL without 
TCR-/t gene deletions the frequency of tal-1 deletions was 
just 1.5% (1/65), in T-ALL with one deleted TCR.-8 allele 
this frequency was 17.6% (6/34) and in T-ALL with TCR-8 
gene deletions on both alleles the frequency of tam deletions 
was substantially higher, 34.3% (12/35). Interestingly, fur- 
ther deletion of the remaining (nonfunctional) TCR-8 genes 
in the T-ALL with a tal-1 deletion was not possible via 8Rnc- 
r rearrangements i  most of them because of deletion of 
the/~l~BC and/or r gene segments (Table 4). Additional 
support for our speculation is found in the observation that 
the hprt deletions probably exclusively occur in TCR-oe/3 + 
T lymphocytes, which generally have TCR-8 gene deletions 
on both alleles. 
Rearrangement studies in which lymphoid cell lines of 
different lineages are transfected with extrachromosomal 
vectors containing the TCR-8 gene-deleting elements and/or 
sil-tal-1 gene constructs might prove whether indeed a spe- 
cial TCR-~ gene-deleting recombinase complex exists and 
whether this enzyme complex is involved in tal-1 deletions. 
Based on our data, we hypothesize that the multiple n- 
zymes of the Ig/TCR gene recombinase complex are differen- 
tially expressed, related to the differentiation lineage and 
differentiation stage of the lymphoid cells. The mechanisms 
regulating such putative differential expression could also de- 
termine the occurrence of oncogenic and nononcogenic rear- 
rangements and deletions in other genes with RSS homolo- 
gous to the Ig and TCR genes. This would explain the 
restriction of particular chromosome aberrations to specific 
types of lymphoid leukemias, uch as tal-1 deletions in T-ALL 
of the c~/3 lineage. 
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